Medscape21h
Management of Acute Severe Ulcerative Colitis
Ulcerative colitis is a chronic relapsing and remitting inflammatory disorder that can generally be managed successfully with maintenance oral medications. However, approximately 15% of patients ...
pharmaphorum1d
Pfizer’s Velsipity heading for NHS use in ulcerative colitis
Up to 25,000 people with ulcerative colitis (UC) in England could be in line for treatment with Pfizer’s once-daily oral therapy Velsipity, after NICE recommended its use by the NHS. The new ...
gut.bmj19h
A reproducible grading scale for histological assessment of inflammation in ulcerative colitis
Email: Karel.Geboes{at}uz.kuleuven.ac.be BACKGROUND Evaluation of histological activity in ulcerative colitis needs to be reproducible but has rarely been tested. This could be useful both clinically ...
gut.bmj5d
Characterisation of mucosal lymphoid aggregates in ulcerative colitis: immune cell phenotype and TcR-γδ expression
Email:Marie-Louise.Hammarstrom{at}climi.umu.se. BACKGROUND AND AIMS A histopathological feature considered indicative of ulcerative colitis (UC) is the so-called basal lymphoid aggregates. Their ...
BMJ5d
Tricyclic antidepressant overdose: a review
The toxic effects of tricyclics are caused by four main pharmacological properties: Inhibition of norepinephrine reuptake at nerve terminals. Direct α adrenergic block. A membrane stabilising or ...